Table of Contents Table of Contents
Previous Page  51 / 65 Next Page
Information
Show Menu
Previous Page 51 / 65 Next Page
Page Background

FOR EXPERT REVIEW PANEL USE ONLY

NOT FOR DISTRIBUTION

(DRM)

2

After removal of outliers repeatability and reproducibility met the SMPR for all matrices

except the Adult Nutritional RTF High Fat Placebo and the Child Formula Powder Milk

Based Placebo; however, method meet SMPR in the fortified versions of these matrices.

Did Method Author Consider ERP’s Method Specific Recommendations (See web link to specific method

comments):

Any Revision to Method Scope/Applicability of Method:

No.

General comments (i.e. safety) about the method:

Feedback from Users of the Methods since being awarded First Action

Official Methods

Status

No user comments reported.

Additional Pros/Strengths:

Method is clearly written, easy to follow, and easy to perform. After the removal of

outliers, repeatability and reproducibility data very good.

Additional Cons/Weaknesses /Concerns

With the SPIFAN matrices data from at least 25% of the laboratories were excluded as

outliers in 9 of the 19 matrices tested. Is this due to instrumentation, sample matrices,

or the way the titration endpoint is determined? Are there additional instructions,

system checks, and/or maintenance procedures that should be added to the

method to improve precision?

Supporting Information

General Comments

Performance Characteristics and compared to approved SMPR:

Analytical Range:

SMPR range 5-500 mg/100g; MLT sample range ~ 20-700 mg/100g.

LOQ: